Data / Form D filings / Lucid Diagnostics Inc.
Lucid Diagnostics Inc.: Form D filings
Lucid Diagnostics Inc., a biotechnology company in New York, NY, filed 4 Form D notices with the SEC between 2023 and 2024. The latest, on December 6, 2024, reports $22 million sold of a $22 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 360 MADISON AVENUE, 25TH FLOOR, New York, NY, 10017
- Phone
- (917) 813-1828
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1799011
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | New notice | $21,950,000 | $21,950,000 | 7 | Nov 22, 2024 | sec.gov | |
| Nov 1, 2023 | New notice | $5,000,000 | $5,000,000 | 2 | Oct 18, 2023 | sec.gov | |
| Apr 5, 2023 | New notice | $11,111,110 | $11,111,110 | 1 | Mar 21, 2023 | sec.gov | |
| Mar 22, 2023 | New notice | $20,000,000 | $13,625,000 | $6,375,000 | 4 | Mar 7, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| MICHAEL A. GORDON | Executive Officer | |
| DENNIS A. MATHEIS | Director | |
| SHAUN M. O'NEIL | Executive Officer | |
| RONALD M. SPARKS | Director | |
| LISHAN AKLOG | Executive Officer, Director | |
| DEBRA J. WHITE | Director | |
| STANLEY N. LAPIDUS | Director | |
| DENNIS M. MCGRATH | Executive Officer | |
| JAMES L. COX | Director | |
| JACQUE J. SOKOLOV | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 2, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lucid Diagnostics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.